Corcept Therapeutics (CORT) PT Lowered to $121 at Piper Sandler
Tweet Send to a Friend
(Updated - August 1, 2025 9:22 AM EDT)
Piper Sandler analyst David Amsellem lowered the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem lowered the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
